Treatment of Long COVID with Dyspnea (Respiratory Distress)
Clinical Scenario
This protocol addresses patients with post COVID-19 condition presenting with dyspnea or respiratory distress
— a recognised long COVID symptom pattern in which breathlessness persists beyond three months after a confirmed COVID-19
diagnosis and cannot be attributed to an alternative cause.
Key Clinical Consideration
When long COVID patients report respiratory distress, underlying cardiopulmonary causes need to be assessed.
Heart and lung-related investigations are an important part of the evaluation to determine whether a newly diagnosable
condition is contributing to the breathlessness.
Treatment Approach
Management focuses on addressing the dyspnea directly: this may involve revisiting medications the patient is already
using — such as inhaled therapies — with consideration given to adjustments in how they are used.
The complete structured regimen, including decision criteria and sequencing, is available via the full protocol.
References
DOI: 10.3947/ic.2024.0024
- Long COVID is defined as the presence of symptoms and signs persisting for more than three months after the diagnosis of coronavirus disease 2019 (COVID-19), which cannot be explained by alternative diagnoses (G, I).
- If long COVID patients complain of respiratory distress, heart and lung-related tests should be considered to evaluate the presence of cardiopulmonary diseases (B, IIa).
- To manage dyspnea reported by patients with long COVID, adjustments in the dosage or frequency of previously used medications (e.g., inhalers) may be considered, or specific treatment for newly diagnosed conditions can be initiated (C, IIb).
View source ↗